RUA Life Sciences plc (RUA.L) LSE
13.00
-0.25(-1.89%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
13.00
-0.25(-1.89%)
Currency In GBp
Address
2 Drummond Crescent
Irvine, KA11 5AN
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 12 9431 7073
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
40
First IPO Date
February 26, 1997
| Name | Title | Pay | Year Born |
| Lachlan Smith | Chief Financial Officer & Director | 156,033 | 1980 |
| William Donald Brown | Chief Executive | 286,053 | 1963 |
| Kathryn Mary Full | Company Secretary | 0 | N/A |
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.